Physician

Pediatric Endocrinology

Allen Kowarski works in the field of Pediatric Endocrinology. He researched medicine at The Hebrew University of Jerusalem Hadassah Medical School. Allen A. Kowarski has written publications. He has 101 publications published with PubMed. The lastest publication is: 'Effect of six months of growth hormone therapy, followed by treatment withdrawal in short children with normal quantitative indexes of growth hormone secretion.'

Publications

---

• The accumulation of IGF-I in kidneys of streptozotocin-diabetic adult rats is not associated with elevated plasma GH or IGF-I levels.
• Plasma cortisol levels increase with age in obese subjects.
• [Idiopathic hypercalcemia].
• METABOLIC OBSERVATIONS ON SALT WASTING IN A PATIENT WITH RENAL DISEASE.
• ALDOSTERONE SECRETION RATE IN CONGENITAL ADRENAL HYPERPLASIA. A DISCUSSION OF THE THEORIES ON THE PATHOGENESIS OF THE SALT-LOSING FORM OF THE SYNDROME.
• EFFECT OF VARIOUS PREPARATIONS OF HUMAN GROWTH HORMONE ON ALDOSTERONE SECRETION RATE OF HYPOPITUITARY DWARFS.
• Hypervitaminosis D. Effect of treatment with sodium sulfate.
• [Salt losing and DOCA-dependent adrenogenital syndrome in a girl].
• Idiopathic hypercalcemia; treatment with sodium sulfate.
• Long-term effects of vasectomy on pituitary-gonadal function in man.
• Testosterone effect on growth and growth mediators of the GH-IGF-I axis in the liver and epiphyseal growth plate of juvenile rats.
• Effect of six months of growth hormone therapy, followed by treatment withdrawal in short children with normal quantitative indexes of growth hormone secretion.
• The relationship of growth rate, plasma growth hormone (GH) concentration, and GH-binding protein.
• Urinary cyclic adenosine 3',5'-monophosphate response in McCune-Albright syndrome: clinical evidence for altered renal adenylate cyclase activity.
• The value of urinary growth hormone determination for assessment of growth hormone deficiency and compliance with growth hormone therapy.
• Plasma integrated concentration of growth hormone after recombinant human growth hormone injection. Implications for determining an optimal dose.
• Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency.
• Short stature: new challenges in growth hormone therapy.
• Growth failure with plasma GH that is normal by RIA but low by radioreceptor assay: responsiveness to exogenous GH.
• Differential accumulation of insulin-like growth factor-I in kidneys of pre- and postpubertal streptozotocin-diabetic rats.
• Plasma IGFBP-3 and its relationship with quantitative growth hormone secretion in short children.
• A comparative study of two dosage forms by a multiple sampling and the constant blood withdrawal methods.
• Increased integrated concentration of norepinephrine, epinephrine, aldosterone, and growth hormone in patients with uncontrolled juvenile diabetes mellitus.
• Simplified method for estimating volume of distribution at steady state.
• A comparative study of urinary 17-hydroxycorticosteroids, urinary free cortisol, and the integrated concentration of plasma cortisol.
• Calculation of oral absorption over short time intervals using clearance and constant blood withdrawal.
• Are constitutional delay of growth and familial short stature different conditions?
• Evaluation of the 6-hour integrated concentration of cortisol as a diagnostic procedure for Cushing's syndrome.
• Adrenal vein epinephrine levels: a useful aid in venous sampling for primary aldosteronism.
• Short term improvement in glycemic control utilizing continuous subcutaneous insulin infusion: the effect on 24-hour integrated concentrations of counterregulatory hor...
• Improved bioassay for insulin by continuous glucose monitoring.
• Correlation of urinary excretion of C-peptide with the integrated concentration and secretion rate of insulin.
• Normal integrated concentration of aldosterone and plasma renin activity: effect of age.
• Integrated concentration of epinephrine and norepinephrine in normal subjects and in patients with mild essential hypertension.
• Dwarfism associated with normal serum growth hormone and increased bioassayable, receptorassayable, and immunoassayable somatomedin.
• Elevated hypoglycemic index and late hyperinsulinism in symptomatic postprandial hypoglycemia.
• Plasma norepinephrine and epinephrine responses to glucagon in patients with suspected pheochromocytomas.
• Estimation of the secretion rate of insulin from the urinary excretion rate of C-peptide. Study in obese and diabetic subjects.
• Integrated concentrations of growth hormone, insulin, C-peptide and prolactin in human obesity.
• The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation.
• The use of the plasma epinephrine response in the diagnosis of idiopathic postprandial syndrome.
• Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation.
• Red cell cotransport activity and sodium content in black men. Relationship to essential hypertension.
• Improved bioassay for glucagon by continuous glucose monitoring.
• Hyperinsulinemia of obesity is due to decreased clearance of insulin.
• Comparative study of immunoactivity and bioactivity of sodium insulin.
• Increased gastric inhibitory polypeptide levels in patients with symptomatic postprandial hypoglycemia.
• A circulating inhibitor of (Na+ + K+)ATPase associated with essential hypertension.
• Advantage of Florisil over charcoal separation in a mechanized testosterone radioimmunoassay.
• Glucocorticoid and partial mineralocorticoid deficiency associated with achalasia.
• Endocrine and exocrine function of intrasplenic pancreatic autografts.
• Catecholamine suppression testing in patient with phaechromocytoma and normal plasma catecholamine levels.
• Diabetes mellitus: customizing management.
• Aldosterone secretion rates in normal subjects from infancy to adulthood.
• Interconversion of cortisol and cortisone in man and its effect on the measurement of cortisol secretion rate.
• Aldosterone secretion rate in the hypertensive form of congenital adrenal hyperplasia.
• Aldosterone secretion and sodium balance in salt-losing nephropathy.
• A dynamic study of plasma renin activity and aldosterone concentration in normal and hypertensive subjects.
• Measurement of plasma dihydrotestosterone by competitive protein-binding analysis.
• Measurement of aldosterone secretion rate by radio-immunoassay.
• Transplacental passage and fetal secretion of aldosterone.
• Measurement of plasma aldosterone by radioimmunoassay.
• Fetal and maternal secretion rate of cortisol in sheep: diffusion resistance of the placenta.
• Problems related to the determination of cortisol secretion rate in man when using "urinary" methods.
• Concentration of testosterone and dihydrotestosterone in subcellular fractions of liver, kidney, prostate, and muscle in the male dog.
• Determination of integrated plasma concentrations and true secretion rates of human growth hormone.
• The transplacental passage of prednisone and prednisolone in pregnancy near term.
• Integrated concentrations of growth hormone correlated with plasma testosterone and bone age in preadolescent and adolescent males.
• Plasma concentration of testosterone, dihydrotestosterone, testosterone-oestradiol binding globulin, and pituitary gonadotrophins in the syndrome of male pseudo-hermap...
• Blood production rate of dihydrotestosterone in the syndrome of male pseudohermaphroditism with testicular feminization.
• Plasma aldosterone concentration at delivery and during the newborn period.
• Comparison of competitive protein binding radioassay of cortisol to double isotope dilution and Porter Silber methods.
• Appraisal of the double isotope dilution techniques for the measurement of plasma aldosterone.
• Plasma aldosterone concentration in normal subjects from infancy to adulthood.
• Integrated concentration and circadian variation of plasma testosterone in normal men.
• Diurnal variation of the metabolic clearance rate of cortisol. Effect on measurement of cortisol production rate.
• The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term.
• Integrated concentration of plasma cortisol in normal subjects.
• Studies on the dynamics of plasma androgens and on the origin of dihydrotestosterone in dogs.
• Growth hormone: metabolic clearance rates, integrated concentrations, and production rates in normal adults and the effect of prednisone.
• Regulation of plasma aldosterone concentration in anephric man and renal transplant recipients.
• Estimation of ACTH reserve on normal and hypopituitary subjects: comparison of oral and intravenous metyrapone with insulin hypoglycemia.
• The effect of ACTH administration on plasma testosterone, dihydrotestosterone and serum LH concentrations in normal men.
• The effect of ACTH administration on aldosterone production in non salt-losing congenital adrenal hyperplasia.
• The regulation of aldosterone secretion in anephric man.
• Effect of operation upon sodium metabolism and aldosterone secretion rate in children.
• The syndrome of congenital adrenocortical unresponsiveness to ACTH. Report of six cases.
• Secretion of cortisol, corticosterone and aldosterone in children with hypopituitarism.
• Congenital adrenal hyperplasia due to a deficiency of one of the enzymes involved in the biosynthesis of pregnenolone.
• Adrenal function in normal infants and in marasmus and kwashiorkor: plasma aldosterone concentration and aldosterone secretion rate.
• The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals.
• In vivo hyperglycemic effect of (-)- and (+)-epinephrine in dogs.
• Diagnosis of reactive hypoglycemia: pitfalls in the use of the oral glucose tolerance test.
• The diagnostic value of the 24 hour integrated concentration of plasma aldosterone.
• Do short children secrete insufficient growth hormone?
• Comparison of assays for growth hormone using monoclonal or polyclonal antibodies for diagnosis of growth disorders.
• Therapy in short children with subnormal integrated concentrations of growth hormone.
• The catecholamine response to hypoglycemia in children with isolated growth hormone deficiency syndromes and multiple pituitary hormone defects.
• Detection of primary aldosteronism by the 6-hour integrated aldosterone/renin ratio.
• Growth impairment due to transient hypercortisolism.

Doctors Specialties

---

• Pediatrics
• Pediatric Endocrinology

Accepted Insurances

---

Education

---

• Johns Hopkins University
• The Hebrew University of Jerusalem Hadassah Medical School

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1700975695
Last Name Of The Provider	KOWARSKI
First Name Of The Provider	ALLEN
View All

Similar Doctors

---

	Dr. Cong Ning, MD This Doctor is OpenDoctor Recommended.
	Dr. Stuart Y. Weich, MD
	Dr. Lewis J. Fermaglich, MD This Doctor is OpenDoctor Recommended.
	Dr. Jean Y. Laurore, MD
	Dr. Liza S. Burns, MD This Doctor is OpenDoctor Recommended.
	Mary S. Burr, MSN

---

Doctor Directory | TOS | twitter | FB | Angel | blog